InMed Pharmaceuticals, Inc.

InMed Pharmaceuticals, Inc.

InMed Pharmaceuticals, Inc.

Overview
Date Founded

1981

Headquarters

200 Granville Street,Suite 340,Vancouver, BC V6C 1S4

Type of Company

Public

Employees (Worldwide)

14

Industries

Pharmaceuticals
Biotechnology

Company Description

InMed Pharmaceuticals, Inc. engages in the development of cannabinoids drug design platform. Its product pipeline includes INM-750 for the treatment of epidermolysis bullosa and INM-085 for the treatment of glaucoma. The company was founded by Christopher Bogart and Craig Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

Executives & Employees

Co-Founder

President, Chief Executive Officer & Director

Chief Financial Officer & Corporate Secretary

Chief Medical Officer

Senior Vice President, Clinical & Regulatory Affairs

Subscribe now to see full list of current and former executives
Board of Directors

Treasurer, Chief Financial & Accounting Officer at Molecular Templates, Inc.

Vice President, Global Alliance Management at Takeda Pharmaceutical Co., Ltd.

Vice President of Corporate Finance & Investment Banking at Eli Lilly & Company

President, Chief Executive Officer & Director at InMed Pharmaceuticals, Inc.

Subscribe now to see full list of current and former board members
Paths to InMed Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
InMed Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

InMed Pharmaceuticals, Inc. issued Units

Details Hidden

InMed Pharmaceuticals, Inc. purchases Biogen Sciences, Inc.

Details Hidden

InMed Pharmaceuticals, Inc. purchases Time Search, Inc. /Calgoo Software Division from Time Search, Inc.

Subscribe now to see full list of recent transations
Transaction Advisors
Accountant

Advised onInMed Pharmaceuticals, Inc. purchases Eworldcentre.com from INToo Software Corp.

Auditor

Advised onInMed Pharmaceuticals, Inc. issued Units

Underwriter

Advised onInMed Pharmaceuticals, Inc. issued Units

Subscribe now to see 4+ more transaction advisors
Subscribe now to see transaction advisors for over 2.5 million organizations
Advisors & Consultants
Subscribe now to see advisors & consultants for over 2.5 million organizations
Scientific Advisor

Chief Scientific Officer & Montreal Site Head at Inception IBD, Inc.

Publicist

Senior Vice President, Investors Relations at Tiberend Strategic Advisors, Inc.

Publicist

Senior Account Executive at Tiberend Strategic Advisors, Inc.

Subscribe now to see advisors & consultants for over 2.5 million organizations
Key Stats and Financials As of 2017
Market Capitalization
$152M
Total Enterprise Value
$12.1M
Earnings Per Share
$-0.05
Revenue
$0
Net Profit
$-4.47M
EBITDA
$-4.38M
Total Debt
$0
Total Equity
$7.97M
Subscribe now to see full financial details